| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Portage Biotech Inc.
13D/A
ALP · G7185A136
|
16.7% |
1/31/2025
Event 1/23/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.